Application no. and date | 16852640.8 (espacenet) (Federated) (European Patent Register), 20160929 | Patent/reg. no. and date | DK/EP 3355884, 20210428 | Publication date | 20180808 | Priority no. and date | US 201562235900 P, 20151001 | EP pub. no. and date |
EP 3355884 20180808 | Effective date | | Applicant/owner | Olema Pharmaceuticals, Inc., 512 2nd Street, 4th Floor
San Francisco, CA 94107, US | Applicant ref. no. | 1602418 | Inventor | KUSHNER, Peter, J., 1362 6th Avenue
San Francisco, CA 94122, US, MYLES, David, C., 79 Roble Road
Berkeley, CA 94705, US, HARMON, Cyrus, L., PO Box 219
Bolinas, CA 94924, US | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | Opponent | | IPC Class | A61K 31/437 (2006.01) , A61K 31/4545 (2006.01) , A61K 31/506 (2006.01) , C07D 471/02 (2006.01) , C07D 471/04 (2006.01) | Title | TETRAHYDRO-1H-PYRIDO[3,4-B]INDOL-ANTIØSTROGENLÆGEMIDLER | Int. application no. | US2016054549 | Int. publication no. | WO2017059139 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|